Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
Clinical trial NCT04238988 · UNKNOWN
Trial details
- NCT number
- NCT04238988
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-18
- Primary completion
- 2023-09-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.